Bone Metastases Are Measurable: The Role of Whole-Body MRI and Positron Emission Tomography.
MRI
PET
bone metastases
measurable
response
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2021
2021
Historique:
received:
08
09
2021
accepted:
04
11
2021
entrez:
6
12
2021
pubmed:
7
12
2021
medline:
7
12
2021
Statut:
epublish
Résumé
Metastatic tumor deposits in bone marrow elicit differential bone responses that vary with the type of malignancy. This results in either sclerotic, lytic, or mixed bone lesions, which can change in morphology due to treatment effects and/or secondary bone remodeling. Hence, morphological imaging is regarded unsuitable for response assessment of bone metastases and in the current Response Evaluation Criteria In Solid Tumors 1.1 (RECIST1.1) guideline bone metastases are deemed unmeasurable. Nevertheless, the advent of functional and molecular imaging modalities such as whole-body magnetic resonance imaging (WB-MRI) and positron emission tomography (PET) has improved the ability for follow-up of bone metastases, regardless of their morphology. Both these modalities not only have improved sensitivity for visual detection of bone lesions, but also allow for objective measurements of bone lesion characteristics. WB-MRI provides a global assessment of skeletal metastases and for a one-step "all-organ" approach of metastatic disease. Novel MRI techniques include diffusion-weighted imaging (DWI) targeting highly cellular lesions, dynamic contrast-enhanced MRI (DCE-MRI) for quantitative assessment of bone lesion vascularization, and multiparametric MRI (mpMRI) combining anatomical and functional sequences. Recommendations for a homogenization of MRI image acquisitions and generalizable response criteria have been developed. For PET, many metabolic and molecular radiotracers are available, some targeting tumor characteristics not confined to cancer type (e.g.
Identifiants
pubmed: 34869009
doi: 10.3389/fonc.2021.772530
pmc: PMC8640187
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
772530Informations de copyright
Copyright © 2021 Oprea-Lager, Cysouw, Boellaard, Deroose, de Geus-Oei, Lopci, Bidaut, Herrmann, Fournier, Bäuerle, deSouza and Lecouvet.
Déclaration de conflit d'intérêts
KH reports personal fees from Bayer, personal fees and other from Sofie Biosciences, personal fees from SIRTEX, non-financial support from ABX, personal fees from Adacap, personal fees from Curium, personal fees from Endocyte, grants and personal fees from BTG, personal fees from IPSEN, personal fees from Siemens Healthineers, personal fees from GE Healthcare, personal fees from Amgen, personal fees from Novartis, personal fees from ymabs, all outside the submitted work. CD reports consultancy for Sirtex, Terumo and PSI CRO, speaker fees from Terumo and Advanced Accelerator Applications and is a member of advisory board for Terumo and Ipsen. EL reports grants from Fondazione AIRC and Italian Ministry of Health, royalties from Springer, lecturer fees from MI&T congressi and ESMIT. LF reports speaker fees from Sanofi, Novartis, Jannssen, and General Electric, congress sponsorship from Guerbet, industrial grant on radiomics from Invectys and Novartis, and co-investigator in grant with Philips, Ariana Pharma, Evolucare. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Eur J Nucl Med Mol Imaging. 2004 Jul;31(7):964-8
pubmed: 14991241
J Nucl Med. 2016 Jun;57(6):867-71
pubmed: 26912439
Clin Cancer Res. 2010 Jun 15;16(12):3215-25
pubmed: 20530698
J Nucl Med. 2017 Jun;58(6):911-919
pubmed: 28232611
Eur J Nucl Med Mol Imaging. 2015 Dec;42(13):2072-82
pubmed: 26219870
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
PLoS One. 2018 Oct 12;13(10):e0205251
pubmed: 30312335
N Engl J Med. 2013 Jul 18;369(3):213-23
pubmed: 23863050
J Nucl Med. 2020 Jun;61(6):799-806
pubmed: 32245899
Ann Oncol. 2012 Apr;23(4):834-43
pubmed: 21896542
Front Oncol. 2017 Aug 07;7:163
pubmed: 28824875
PET Clin. 2019 Jan;14(1):121-133
pubmed: 30420214
J Magn Reson Imaging. 2021 Aug;54(2):401-408
pubmed: 33694240
J Clin Oncol. 2013 Oct 1;31(28):3525-30
pubmed: 24002508
Bioorg Med Chem. 2012 Feb 15;20(4):1502-10
pubmed: 22264762
Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6213s-6216s
pubmed: 17062703
J Nucl Med. 2016 Jul;57(7):996-1001
pubmed: 27173163
Eur Radiol. 2021 Aug;31(8):6001-6012
pubmed: 33492473
Bone. 2019 Mar;120:254-261
pubmed: 30445200
Eur J Cancer. 2011 Jan;47(2):277-86
pubmed: 20863686
Eur Urol. 2017 Jan;71(1):81-92
pubmed: 27317091
Radiology. 2014 Jun;271(3):785-94
pubmed: 24475858
Radiol Imaging Cancer. 2021 Jul;3(4):e200069
pubmed: 34170199
J Am Acad Orthop Surg. 2019 May 15;27(10):345-355
pubmed: 30394910
Lancet. 2010 Apr 24;375(9724):1437-46
pubmed: 20398925
Contrast Media Mol Imaging. 2011 Nov-Dec;6(6):413-20
pubmed: 22162137
Cancers (Basel). 2019 Dec 20;12(1):
pubmed: 31861942
Radiologe. 2015 Feb;55(2):120-6
pubmed: 25589421
Radiology. 2018 Mar;286(3):948-959
pubmed: 29095674
Int J Cancer. 2013 Jan 15;132(2):E37-47
pubmed: 22890912
J Thorac Oncol. 2009 Mar;4(3):429-31
pubmed: 19247091
J Bone Miner Res. 2018 Dec;33(12):2099-2113
pubmed: 30476357
Eur J Radiol. 2010 Apr;74(1):231-5
pubmed: 19285820
J Natl Cancer Inst. 2005 Jan 5;97(1):59-69
pubmed: 15632381
Radiology. 2009 Aug;252(2):624
pubmed: 19703896
Nature. 2005 Jun 16;435(7044):969-73
pubmed: 15959517
Int J Oncol. 2012 Dec;41(6):2087-92
pubmed: 23041906
Front Oncol. 2021 Mar 17;11:578093
pubmed: 33816225
J Nucl Med. 2015 Mar;56(3):365-71
pubmed: 25678491
Ann Oncol. 2017 Jul 1;28(suppl_4):iv1-iv21
pubmed: 28881918
Eur Radiol. 2016 May;26(5):1404-11
pubmed: 26215436
Nucl Med Commun. 2020 Apr;41(4):377-382
pubmed: 32058446
J Nucl Med. 2018 Oct;59(10):1516-1523
pubmed: 29626121
Radiology. 2020 Dec;297(3):622-629
pubmed: 33078998
J Nucl Med. 2020 May;61(5):671-675
pubmed: 31586004
Oncol Rev. 2017 May 09;11(1):321
pubmed: 28584570
EJNMMI Phys. 2020 May 25;7(1):35
pubmed: 32451783
Cureus. 2020 May 13;12(5):e8095
pubmed: 32542150
Ann Oncol. 2016 Apr;27(4):619-24
pubmed: 26598545
Eur Radiol. 2011 Oct;21(10):2169-77
pubmed: 21710270
Eur J Radiol. 2012 May;81(5):1007-15
pubmed: 21354739
J Magn Reson Imaging. 2020 Dec 31;:
pubmed: 33382151
J Nucl Med. 2017 Dec;58(12):1962-1968
pubmed: 28522740
J Nucl Med. 2020 Sep;61(9):1320-1325
pubmed: 31924729
Ann Palliat Med. 2020 Mar;9(2):247-255
pubmed: 32233618
Sci Rep. 2017 Mar 23;7(1):358
pubmed: 28336974
Eur J Cancer. 2017 May;77:109-116
pubmed: 28390297
J Natl Cancer Inst. 2007 Dec 5;99(23):1753-67
pubmed: 18042932
J Clin Oncol. 2014 Sep 20;32(27):3059-68
pubmed: 25113753
Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):161-175
pubmed: 32564171
Mol Imaging Biol. 2020 Apr;22(2):397-406
pubmed: 31236756
Eur J Gynaecol Oncol. 2015;36(6):672-6
pubmed: 26775349
Ann Nucl Med. 2019 Jul;33(7):502-511
pubmed: 30982124
Eur J Cancer. 2014 Oct;50(15):2519-31
pubmed: 25139492
J Clin Oncol. 2000 Nov 1;18(21):3651-64
pubmed: 11054438
J Nucl Med. 2018 Jan;59(1):38-43
pubmed: 28637802
Eur Radiol. 2021 Sep;31(9):7012-7021
pubmed: 33715090
Lancet Oncol. 2013 Oct;14(11):e465-e475
pubmed: 24079874
Ann Oncol. 2021 Mar;32(3):404-411
pubmed: 33278600
Nucl Med Commun. 2021 Nov 1;42(11):1254-1260
pubmed: 34284438
Br J Cancer. 2009 Oct 20;101(8):1225-32
pubmed: 19789531
Radiology. 2020 May;295(2):328-338
pubmed: 32154773
PET Clin. 2018 Oct;13(4):505-522
pubmed: 30219185
Ann Diagn Pathol. 2011 Apr;15(2):79-83
pubmed: 21163679
J Nucl Med. 2020 Aug;61(8):1145-1152
pubmed: 31806776
J Nucl Med. 2018 Mar;59(3):469-478
pubmed: 29123012
Eur J Radiol. 2008 Jan;65(1):47-58
pubmed: 18082989
Radiology. 2016 May;279(2):345-65
pubmed: 27089188
J Nucl Med. 2009 May;50 Suppl 1:122S-50S
pubmed: 19403881
Eur J Radiol. 2015 Apr;84(4):623-30
pubmed: 25641009
J Nucl Med. 2014 Feb;55(2):191-7
pubmed: 24309383
Cancer Imaging. 2020 Oct 27;20(1):77
pubmed: 33109268
J Nucl Med. 2012 Jun;53(6):939-46
pubmed: 22582046
Radiology. 2014 Nov;273(2):539-48
pubmed: 24865311
Eur Radiol. 2010 Dec;20(12):2973-82
pubmed: 20661742
Oncotarget. 2014 Dec 15;5(23):12448-58
pubmed: 25504434
Pediatr Blood Cancer. 2020 Nov;67(11):e28605
pubmed: 32706520
Br J Radiol. 2018 Jan;91(1081):20170508
pubmed: 29164924
Eur J Radiol. 2009 Jun;70(3):393-400
pubmed: 19457631
N Engl J Med. 2017 Nov 9;377(19):1836-1846
pubmed: 29117498
Acad Radiol. 2018 Nov;25(11):1405-1414
pubmed: 29627288
EJNMMI Res. 2019 Feb 7;9(1):14
pubmed: 30734113
Ther Adv Med Oncol. 2021 Feb 24;13:1758835920987654
pubmed: 33708265
Eur J Nucl Med Mol Imaging. 2019 May;46(5):1063-1072
pubmed: 30569186
Eur Radiol. 2021 Aug;31(8):6136-6144
pubmed: 33496828
Diagnostics (Basel). 2018 Jul 09;8(3):
pubmed: 29987207
Nucl Med Commun. 2015 Dec;36(12):1165-73
pubmed: 26397999
Lancet Oncol. 2019 Sep;20(9):1286-1294
pubmed: 31375469
Clin Exp Metastasis. 2020 Aug;37(4):551-560
pubmed: 32519046
Eur Radiol. 2019 Sep;29(9):4812-4821
pubmed: 30689031
Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):412-422
pubmed: 29192365
Eur Radiol. 2019 Jul;29(7):3945-3954
pubmed: 30859285
Eur J Nucl Med Mol Imaging. 2016 Dec;43(13):2360-2373
pubmed: 27470327
Radiology. 1988 Oct;169(1):45-8
pubmed: 3262228
Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):70-83
pubmed: 26508290
Br J Cancer. 2015 Apr 28;112(9):1452-60
pubmed: 25871331
Eur Radiol. 2013 Jul;23(7):1986-97
pubmed: 23455764
Theranostics. 2016 Jan 01;6(2):262-71
pubmed: 26877784
Ann Oncol. 2020 Dec;31(12):1623-1649
pubmed: 32979513
Clin Cancer Res. 1998 Jul;4(7):1765-72
pubmed: 9676853
Breast. 2018 Aug;40:82-84
pubmed: 29709728
Lung Cancer. 2008 Jan;59(1):48-56
pubmed: 17850919
Ann Nucl Med. 2019 May;33(5):351-361
pubmed: 30877561
Cancer Metastasis Rev. 2001;20(3-4):333-49
pubmed: 12085970
Magn Reson Med Sci. 2007;6(3):147-55
pubmed: 18037795
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv192-iv237
pubmed: 30285222
Cancer Treat Rev. 2001 Jun;27(3):165-76
pubmed: 11417967
J Clin Oncol. 2016 Sep 1;34(25):3069-103
pubmed: 27217461
Diagnostics (Basel). 2021 Apr 07;11(4):
pubmed: 33917006
Ann Oncol. 2013 Oct;24 Suppl 6:vi99-105
pubmed: 23813929
Joint Bone Spine. 2017 Dec;84(6):677-684
pubmed: 28499894
Oncologist. 2020 Oct;25(10):835-844
pubmed: 32374053
Prostate. 2005 Oct 1;65(2):178-87
pubmed: 15948151
Semin Nucl Med. 2021 Mar;51(2):170-177
pubmed: 33509373
EJNMMI Phys. 2019 Dec 26;6(1):28
pubmed: 31879795
Eur Radiol. 2018 Apr;28(4):1687-1691
pubmed: 29134357
Eur Radiol. 2021 Nov;31(11):8714-8724
pubmed: 33912991
Eur J Nucl Med Mol Imaging. 2019 Dec;46(13):2630-2637
pubmed: 31280350
Bone. 2021 Mar;144:115821
pubmed: 33348127
Front Med (Lausanne). 2020 Jan 29;6:336
pubmed: 32118000
Pract Radiat Oncol. 2017 Jan - Feb;7(1):4-12
pubmed: 27663933
J Nucl Med. 2019 Sep;60(9):1221-1227
pubmed: 30850488
BMC Cancer. 2019 Nov 12;19(1):1091
pubmed: 31718602
Acad Radiol. 2012 Mar;19(3):349-57
pubmed: 22173321
J Nucl Med. 2019 Sep;60(9):1277-1283
pubmed: 30850484
Cancer Imaging. 2011 Oct 03;11 Spec No A:S129-45
pubmed: 22185786
Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):821-830
pubmed: 30506455
Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):11-20
pubmed: 24072344
Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1344-1361
pubmed: 29500480
Mol Imaging Biol. 2019 Feb;21(1):1-10
pubmed: 29516387
Surg Oncol. 2013 Jun;22(2):86-91
pubmed: 23726506
Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):313-315
pubmed: 32385645
Phys Med. 2021 Mar;83:122-137
pubmed: 33765602
J Natl Cancer Inst. 2000 Feb 2;92(3):205-16
pubmed: 10655437
Oncologist. 2019 Dec;24(12):e1277-e1285
pubmed: 31337657
J Nucl Med. 2018 Jan;59(1):3-12
pubmed: 28935835
Radiology. 2016 Aug;280(2):576-84
pubmed: 26909647
J Clin Oncol. 2007 Aug 1;25(22):3281-7
pubmed: 17664475
J Nucl Med. 2019 Jun;60(6):801-805
pubmed: 30954939
Eur Urol Oncol. 2018 May;1(1):78-82
pubmed: 31100231
J Nucl Med. 2019 Dec;60(12):1730-1735
pubmed: 31000583
J Nucl Med. 2004 Sep;45(9):1519-27
pubmed: 15347719
Eur Urol. 2012 Jul;62(1):68-75
pubmed: 22366187
Br J Haematol. 2016 Jul;174(1):127-35
pubmed: 26991959
PLoS One. 2014 Apr 07;9(4):e91779
pubmed: 24710083
Clin Positron Imaging. 1999 May;2(3):159-171
pubmed: 14516540
Br J Radiol. 2018 Jan;91(1081):20170577
pubmed: 29076749
EJNMMI Phys. 2018 Dec 7;5(1):35
pubmed: 30523429
Magn Reson Imaging Clin N Am. 2011 Feb;19(1):181-209
pubmed: 21129641
J Nucl Med. 2021 May 28;:
pubmed: 34049980
Eur Radiol. 2009 Oct;19(10):2495-507
pubmed: 19468736
Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2045-2054
pubmed: 29980832
Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):493-500
pubmed: 32789680
J Clin Oncol. 2006 Oct 20;24(30):4818-24
pubmed: 17050866
Ann Oncol. 2019 Aug 1;30(8):1194-1220
pubmed: 31161190
Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2395-2404
pubmed: 33797596
J Nucl Med. 2014 Sep;55(9):1417-23
pubmed: 24970910
Acta Radiol. 2012 Dec 1;53(10):1164-72
pubmed: 23047848
Clin Radiol. 1999 Jul;54(7):448-51
pubmed: 10437696
AJR Am J Roentgenol. 1986 Feb;146(2):353-8
pubmed: 3484586
EJNMMI Res. 2019 Jan 24;9(1):6
pubmed: 30680469
Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):469-476
pubmed: 32617640
Eur Radiol. 2020 Jul;30(7):3641-3649
pubmed: 32125513
Nucl Med Commun. 2021 Aug 1;42(8):839-845
pubmed: 33741854
Clin Nucl Med. 2021 Apr 1;46(4):271-282
pubmed: 33651022
EJNMMI Res. 2020 Apr 19;10(1):40
pubmed: 32307594
JAMA Oncol. 2018 Feb 1;4(2):217-224
pubmed: 29121144
Cancer Res. 1990 Dec 1;50(23):7710-6
pubmed: 2253214
J Clin Med. 2020 May 08;9(5):
pubmed: 32397223
J Nucl Med. 2021 Jan;62(1):30-36
pubmed: 32532925
Eur Urol Focus. 2016 Dec;2(5):540-546
pubmed: 28723520
Theranostics. 2021 Feb 16;11(9):4050-4060
pubmed: 33754047
J Nucl Med. 2020 Jul;61(7):1014-1020
pubmed: 31806775
J Clin Oncol. 2012 Feb 10;30(5):519-24
pubmed: 22231045
Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1553-62
pubmed: 24652233
Oncol Lett. 2014 Jun;7(6):1997-2002
pubmed: 24932278
Acta Radiol. 2011 Jun 1;52(5):557-61
pubmed: 21498309
Ann Oncol. 2015 Jun;26(6):1048-1057
pubmed: 25471332
Invest Radiol. 2018 Feb;53(2):96-102
pubmed: 28906339